DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Chapple C, Rechberger T, Al-Shukri S.
Randomized, double-blind, placebo- and tolterodine-controlled trial of once-daily antimuscarinic agent solifenacin in patients with symptomatic averactive bladder.
BJU Int 2004; 93: 303-310
We do not assume any responsibility for the contents of the web pages of other providers.